Cancer Genetics Price Performance
CGIX opened at $1.32 on Monday. The company’s 50 day moving average is $0.88 and its 200 day moving average is $0.81. Cancer Genetics has a 12-month low of $2.11 and a 12-month high of $17.50.
Cancer Genetics Company Profile
- Get a free copy of the StockNews.com research report on Cancer Genetics (CGIX)
- Salesforce Cuts Labor, Shows Strong Earnings Despite Challenges
- Institutional Support for Analog Devices Remains High
- Three CBD Stocks to Dominate a Budding Industry
- Microsoft Shares: Is it Time to Back Up the Truck?
- Is the 60/40 Portfolio Mix Still in Vogue?
Receive News & Ratings for Cancer Genetics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cancer Genetics and related companies with MarketBeat.com's FREE daily email newsletter.